On March 5, 2018 Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company pioneering the development of medicines to control the expression of genes, reported that its Chief Executive Officer, Nancy Simonian, M.D., will present a corporate overview at upcoming investor conferences (Press release, Syros Pharmaceuticals, MAR 5, 2018, View Source [SID1234524370]). Details are as follows:
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
(Cowen and Company 38th Annual Health Care Conference
Date: Monday, March 12
Time: 12:00 p.m. ET
Location: The Boston Marriott Copley Place, 110 Huntington Avenue, Boston, MA
Oppenheimer 28th Annual Healthcare Conference
Date: Wednesday, March 21
Presentation Time: 2:10 p.m. ET
Location: The Westin New York Grand Central, 212 East 42nd Street, New York, NY
A live webcast of each presentation will be available on the Investors & Media section of the Syros website at www.syros.com. An archived replay of the webcast will be available for approximately 30 days following each presentation.